Published in Gene Therapy Weekly, January 19th, 2012
"It was shown that the fetus could represent an ideal recipient because of his immunologic early naivete in gestation that reduces the risk of immunoreactions. Clinical experience in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.